Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Asmar

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Blood Pressure Monitoring|May 11, 2000
Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensivesL Ribeiro, G Gama, A Santos, et al.
Journal of Human Hypertension|May 14, 1998
Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover studyJ Topouchian, A M Brisac, B Pannier, et al.
The American Journal of the Medical Sciences|February 1, 1994
Sodium, large arteries, and diuretic compounds in hypertensionM E Safar, R Asmar, A Benetos, et al.
Blood Pressure|May 3, 2001
The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertensionA Himmelmann, S Keinänen-Kiukaanniemi, A Wester, et al.
International Journal of Clinical Practice|April 20, 2006
A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoringJ-P Baguet, S Nisse-Durgeat, S Mouret, et al.
Vascular Health and Risk Management|May 14, 2009
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC studyJ P Baguet, R Asmar, P Valensi, et al.
Journal of Human Hypertension|February 1, 1996
Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertensionA Bénétos, A Laflèche, R Asmar, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 24, 2001
[Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]A Hornych, M Marre, A Mimran, et al.
Journal of Hypertension|October 11, 2001
High blood pressure and associated cardiovascular risk factors in FranceR Asmar, S Vol, B Pannier, et al.
The American Journal of Cardiology|February 15, 1996
Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertensionR Asmar, A Benetos, B Pannier, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Blood Pressure Monitoring|May 11, 2000
Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensivesL Ribeiro, G Gama, A Santos, et al.
Journal of Human Hypertension|May 14, 1998
Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover studyJ Topouchian, A M Brisac, B Pannier, et al.
The American Journal of the Medical Sciences|February 1, 1994
Sodium, large arteries, and diuretic compounds in hypertensionM E Safar, R Asmar, A Benetos, et al.
Blood Pressure|May 3, 2001
The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertensionA Himmelmann, S Keinänen-Kiukaanniemi, A Wester, et al.
International Journal of Clinical Practice|April 20, 2006
A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoringJ-P Baguet, S Nisse-Durgeat, S Mouret, et al.
Vascular Health and Risk Management|May 14, 2009
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC studyJ P Baguet, R Asmar, P Valensi, et al.
Journal of Human Hypertension|February 1, 1996
Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertensionA Bénétos, A Laflèche, R Asmar, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 24, 2001
[Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations]A Hornych, M Marre, A Mimran, et al.
Journal of Hypertension|October 11, 2001
High blood pressure and associated cardiovascular risk factors in FranceR Asmar, S Vol, B Pannier, et al.
The American Journal of Cardiology|February 15, 1996
Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertensionR Asmar, A Benetos, B Pannier, et al.
Pageof 11